Pharma & Healthcare

Pharma and Healthcare Market Research Reports

Pharma & Healthcare Market Research Reports, Analysis & Trends

Sub-Categories

Publication Single User License (PDF) Price
Regis Healthcare Ltd : Company Profile and SWOT Analysis

Regis Healthcare Ltd : Company Profile and SWOT Analysis

Date Published: Dec 21 2014

This report is a crucial resource for industry executives and anyone looking to access key information about "Regis Healthcare Ltd"

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

$125.00
Taisho Pharmaceutical Holdings Co., Ltd. : Company Profile and SWOT Analysis

Taisho Pharmaceutical Holdings Co., Ltd. : Company Profile and SWOT Analysis

Date Published: Dec 21 2014

This report is a crucial resource for industry executives and anyone looking to access key information about "Taisho Pharmaceutical Holdings Co., Ltd."

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

$125.00
Catalent, Inc. : Company Profile and SWOT Analysis

Catalent, Inc. : Company Profile and SWOT Analysis

Date Published: Dec 20 2014

This report is a crucial resource for industry executives and anyone looking to access key information about "Catalent, Inc."

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

$125.00
Philippines Pharmaceuticals and Healthcare Report Q1 2015

Philippines Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Our outlook for the Philippines' pharmaceutical sector remains bullish, driven by an increasing
population and high burden of disease profile. Generic medicines will continue to account for an increasing
share of pharmaceutical sales in the Philippines, galvanised by expanding government provision of
healthcare as well as improvements in generic drug distribution. This provides strong growth opportunities
for generic drug manufacturers in an emerging market where economic growth will be sustained by robust

$1,295.00
Saudi Arabia Medical Devices Report Q1 2015

Saudi Arabia Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: The late-November 2014 decision by OPEC to maintain its oil production ceiling, and
thereby allowing lower crude prices for the coming months, raises downside risks to the Saudi Arabian
medical device expenditure forecast. While the country is relatively well-placed to withstand lower
government revenue, mainly due to its considerable foreign currency reserves and assets, questions will be
increasingly raised over budget allocations, including state-funded healthcare projects.
Headline Industry Forecasts

$1,295.00
United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: The pharmaceutical and healthcare markets of the United Kingdom are driven by government
spending in the form of the National Health System (NHS), which accounts for over 80% of total healthcare
spending. With a higher prevalence of non-communicable diseases, coupled with an ageing population, the
increased demand for healthcare may lead to the enforcement of cost-containment strategies and movement
away from expensive treatment options.
Headline Expenditure Projections

$1,295.00
Switzerland Medical Devices Report Q1 2015

Switzerland Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: The Swiss medical device market is expected to grow by a CAGR of 1.4% over the
2013-2018 period, with other medical devices and orthopaedics & prosthetics expected to have the highest
growth during this period. Over the last 15 years the Swiss medical technology sector has grown faster than
almost any other sector in the country. Government technology development programmes, favourable tax
rates, quality staff and research have all contributed.
Headline Industry Forecasts

$1,295.00
Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015

Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: The World Health Organization's approval of a quality control laboratory for medicines in
Zimbabwe is a positive step for the country's pharmaceutical market. It will help to reduce the proportion of
counterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers.
Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budget
and underdeveloped local manufacturing industry will continue to limit investment.
Headline Expenditure Projections

$1,295.00
United States Medical Devices Report Q1 2015

United States Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: The US medical market is forecast to see steady growth over the next five years,
despite a slowdown in health spending, the impact of the newly introduced Medical Device Excise Tax and
uncertainties within the healthcare system in the wake of the Patient Protection and Affordable Care Act.
Imports have been growing in line with the market, which remains by far the world's largest. Exports are
continuing to rise as US manufacturers seek out opportunities in emerging global markets.
Headline Industry Forecasts

$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q1 2015

Bahrain Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Our outlook for Bahrain's pharmaceutical and healthcare sector remains strong, with the
government announcing the development and expansion of health centres across the country in addition to
several preventive health projects planned. Despite recent price cuts negatively impacting the market in the
short term, we believe an ageing population, increasing chronic disease burden and robust economic
growth will drive medicine demand for many years to come.
Headline Expenditure Projections

$1,295.00
Bangladesh Pharmaceuticals and Healthcare Report Q1 2015

Bangladesh Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade.
Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicable
diseases, this represents an epidemiological transition that will present new opportunities for
pharmaceutical companies.
Headline Expenditure Projections
■ Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4%
in local currency terms and +11.9% in US dollar terms

$1,295.00
Belarus Pharmaceuticals and Healthcare Report Q1 2015

Belarus Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: The Belarusian market will suffer from the impact of depreciation and economic instability as
the country's economy becomes ever more reliant on Russian loans to function. Furthermore, wage growth
mandated by the government will become unsustainable, threatening to dampen internal consumption.
Belarus will present little reward for high risk for most pharmaceutical companies in the region.
Headline Expenditure Projections
Pharmaceuticals: BYR8,927bn in 2013 (USD1.00bn) to BYR11,490bn (USD1.09bn) in 2014; +28.7% in

$1,295.00
China Pharmaceuticals and Healthcare Report Q1 2015

China Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Improvements in intellectual property protection, an ageing population and increasing access
to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug
manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal
practices.
Headline Expenditure Projections
■ Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7%
in local currency and +16.1% in US dollar terms.

$1,295.00
Finland Pharmaceuticals and Healthcare Report Q1 2015

Finland Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Finland, like many other Western countries, has a mature pharmaceutical market where growth
is slowing. Although an ageing population will drive the demand for high-value medicines for the treatment
of long-term illnesses, drug manufacturers will be pressured to reduce drug prices as the government
increases its cost-containment measures. Political uncertainty along with the country's weak economic
outlook adds further downward pressure to our forecast.
Headline Expenditure Projections

$1,295.00
Indonesia Medical Devices Report Q1 2015

Indonesia Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: The Indonesian medical device market remains one of the fastest growing worldwide
with growth averaging 12.7% per annum. The best opportunities still remain in and around Java and
surrounding areas but healthcare provision in the rural parts of the country remain underdeveloped.
Headline Industry Forecasts
■ The Indonesian medical device market, in US dollar terms, is projected to rise by a CAGR of 12.7%,
which should bring it from an estimated US$672.8mn in 2013 to US$1,221.9mn in 2018. Indonesia's

$1,295.00
India Pharmaceuticals and Healthcare Report Q1 2015

India Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: The new government under Prime Minister Modi bodes well for the overall pharmaceutical
sector. The proposed introduction of universal healthcare in 2015 coupled with small regulatory reform will
help unlock the potential of the large Indian market.
Headline Expenditure Projections
Pharmaceuticals: INR904.0bn (USD15.4bn) in 2013 to INR1,021.8bn (USD17.0bn) in 2014; +13.0% in
local currency terms and +10.36% in US dollar terms.
Healthcare: INR4,640bn (USD79.2bn) in 2013 to INR5,179.9bn (USD86.3bn) in 2014; +11.6% in local

$1,295.00
Norway Medical Devices Report Q1 2015

Norway Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: The Norwegian medical device market is limited by the size of the population, but
enjoys above average per capita spending of US$294. The market is projected to grow at a US dollar
CAGR of 3.1% to 2018 with the ageing population the main growth driver. The market will continue to be
import-led with much of domestic production geared to the export market.
Headline Industry Forecasts
■ In 2013, the medical device market is estimated at US$1,483mn, equal to US$294 per capita. The market

$1,295.00
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2015

Kazakhstan Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Dec 17 2014

BMI View: Plans to boost government spending on healthcare will be positive for the pharmaceutical
industry as well as other participants in the healthcare sector. Over the longer term, the introduction of
compulsory health insurance will create a large pool of funding for further growth. However, a key risk to
our outlook is oil prices and their effect on Kazakh government revenues.
Headline Expenditure Projections
■ Pharmaceuticals: KZT273.92bn (USD1.80bn) in 2013 to KZT335.18bn (USD1.84bn) in 2014; +22.4%

$1,295.00
Peru Medical Devices Report Q1 2015

Peru Medical Devices Report Q1 2015

Date Published: Dec 17 2014

BMI Industry View: Peru represents the second smallest medical device market in the Americas region and
has one of the lowest rates of per capita medical device spending in the region, which indicates potential for
growth. With a 2013-2018 CAGR projected at around the regional average rate, the market is expected to
remain significantly smaller than neighbouring Latin American countries. Lima remains the most attractive
area in the private sector, as the urban population has more disposable income to spend on medical

$1,295.00
High-Grade Glioma - Pipeline Review, H2 2014

High-Grade Glioma - Pipeline Review, H2 2014

Date Published: Dec 15 2014

High-Grade Glioma - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H2 2014’, provides an overview of the High-Grade Glioma’s therapeutic pipeline.

$2,000.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data